A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma

This study is aimed at investigating tumoral and inflammatory cells and the significance of the prognostic factors of pancreatic ductal adenocarcinoma (PDAC); it is also aimed at determining the role of immunohistochemistry in the diagnosis and prognosis of this neoplasm. Materials and Methods. 230...

Full description

Bibliographic Details
Main Authors: Vlad Herlea, Elena Stoica Mustafa, Andreea Cristina Iorgescu, Nicolae Catalin Pechianu, Dragos Cretoiu, Maria Sajin, Simona Olimpia Dima, Catalin Vasilescu, Cezar Stroescu, Constantin Ungureanu, Traian Dumitrascu, Vladislav Brasoveanu, Minerva Ghinescu, Irinel Popescu
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2020/6148286
id doaj-a1b1a7c7085f45b08a2786f5464023df
record_format Article
spelling doaj-a1b1a7c7085f45b08a2786f5464023df2020-11-25T03:55:01ZengHindawi LimitedJournal of Immunology Research2314-88612314-71562020-01-01202010.1155/2020/61482866148286A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal AdenocarcinomaVlad Herlea0Elena Stoica Mustafa1Andreea Cristina Iorgescu2Nicolae Catalin Pechianu3Dragos Cretoiu4Maria Sajin5Simona Olimpia Dima6Catalin Vasilescu7Cezar Stroescu8Constantin Ungureanu9Traian Dumitrascu10Vladislav Brasoveanu11Minerva Ghinescu12Irinel Popescu13Department of Pathology, Fundeni Clinical Institute, Bucharest 022328, RomaniaDepartment of Pathology, Fundeni Clinical Institute, Bucharest 022328, RomaniaDepartment of Pathology, Fundeni Clinical Institute, Bucharest 022328, RomaniaDepartment of Pathology, Fundeni Clinical Institute, Bucharest 022328, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest 020021, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest 020021, RomaniaCenter of Excellence for Translational Medicine, Fundeni Clinical Institute, Bucharest, Romania“Carol Davila” University of Medicine and Pharmacy, Bucharest 020021, RomaniaCenter of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest 022328, RomaniaCenter of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest 022328, RomaniaCenter of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest 022328, Romania“TituMaiorescu” University, Faculty of Medicine, Bucharest 031593, Romania“TituMaiorescu” University, Faculty of Medicine, Bucharest 031593, Romania“TituMaiorescu” University, Faculty of Medicine, Bucharest 031593, RomaniaThis study is aimed at investigating tumoral and inflammatory cells and the significance of the prognostic factors of pancreatic ductal adenocarcinoma (PDAC); it is also aimed at determining the role of immunohistochemistry in the diagnosis and prognosis of this neoplasm. Materials and Methods. 230 cases of pancreatic ductal adenocarcinoma were included in the study group; these cases were selected from the archives of the Department of Pathology of the Fundeni Clinical Institute over a ten-year period. Immunohistochemistry was performed using the following antibodies: MUC 1, CD 34, Factor VIII, CD 68, MMP-7, CEA, p21, p53, and Ki 67. Results. There were 133 male (57.8%) and 97 female (42.2%) patients included in this study, with ages between 20 and 81 years old (mean age: 58.2 years) and with tumors located in the pancreatic head (n=196; 85.2%), pancreatic body (n=12; 5.2%), and pancreatic tail (n=20, 8.7%), as well as panpancreatic tumors (n=2; 0.9%). Patients presented with early stages (IA and IB), with low pathologic grade (G1), with small size tumors (less than 1-1.5 cm), with tumors located in the head of the pancreas, (p53: negative; p21: positive; and CD 68: positive in peritumoral tissue), with low nuclear index (Ki 67<10%), without metastases at the time of surgery (had a better prognosis), and with a survival rate of about 7 months. Conclusions. Immunohistochemistry is useful for an accurate diagnosis, differential diagnosis, and establishment of additional factors that might have a prognostic importance. It is recommended to study peritumoral tissue from the quantitative and qualitative points of view to increase the number of prognostic factors. This study represents a multidisciplinary approach, and it is a result of teamwork; it presents histopathological methods of examination of this severe illness and describes only a part of the scientific effort to determine the main pathological mechanisms of this neoplasm.http://dx.doi.org/10.1155/2020/6148286
collection DOAJ
language English
format Article
sources DOAJ
author Vlad Herlea
Elena Stoica Mustafa
Andreea Cristina Iorgescu
Nicolae Catalin Pechianu
Dragos Cretoiu
Maria Sajin
Simona Olimpia Dima
Catalin Vasilescu
Cezar Stroescu
Constantin Ungureanu
Traian Dumitrascu
Vladislav Brasoveanu
Minerva Ghinescu
Irinel Popescu
spellingShingle Vlad Herlea
Elena Stoica Mustafa
Andreea Cristina Iorgescu
Nicolae Catalin Pechianu
Dragos Cretoiu
Maria Sajin
Simona Olimpia Dima
Catalin Vasilescu
Cezar Stroescu
Constantin Ungureanu
Traian Dumitrascu
Vladislav Brasoveanu
Minerva Ghinescu
Irinel Popescu
A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma
Journal of Immunology Research
author_facet Vlad Herlea
Elena Stoica Mustafa
Andreea Cristina Iorgescu
Nicolae Catalin Pechianu
Dragos Cretoiu
Maria Sajin
Simona Olimpia Dima
Catalin Vasilescu
Cezar Stroescu
Constantin Ungureanu
Traian Dumitrascu
Vladislav Brasoveanu
Minerva Ghinescu
Irinel Popescu
author_sort Vlad Herlea
title A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma
title_short A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma
title_full A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma
title_fullStr A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma
title_full_unstemmed A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma
title_sort morphological and immunohistochemical study of the tumoral and inflammatory cells in pancreatic ductal adenocarcinoma
publisher Hindawi Limited
series Journal of Immunology Research
issn 2314-8861
2314-7156
publishDate 2020-01-01
description This study is aimed at investigating tumoral and inflammatory cells and the significance of the prognostic factors of pancreatic ductal adenocarcinoma (PDAC); it is also aimed at determining the role of immunohistochemistry in the diagnosis and prognosis of this neoplasm. Materials and Methods. 230 cases of pancreatic ductal adenocarcinoma were included in the study group; these cases were selected from the archives of the Department of Pathology of the Fundeni Clinical Institute over a ten-year period. Immunohistochemistry was performed using the following antibodies: MUC 1, CD 34, Factor VIII, CD 68, MMP-7, CEA, p21, p53, and Ki 67. Results. There were 133 male (57.8%) and 97 female (42.2%) patients included in this study, with ages between 20 and 81 years old (mean age: 58.2 years) and with tumors located in the pancreatic head (n=196; 85.2%), pancreatic body (n=12; 5.2%), and pancreatic tail (n=20, 8.7%), as well as panpancreatic tumors (n=2; 0.9%). Patients presented with early stages (IA and IB), with low pathologic grade (G1), with small size tumors (less than 1-1.5 cm), with tumors located in the head of the pancreas, (p53: negative; p21: positive; and CD 68: positive in peritumoral tissue), with low nuclear index (Ki 67<10%), without metastases at the time of surgery (had a better prognosis), and with a survival rate of about 7 months. Conclusions. Immunohistochemistry is useful for an accurate diagnosis, differential diagnosis, and establishment of additional factors that might have a prognostic importance. It is recommended to study peritumoral tissue from the quantitative and qualitative points of view to increase the number of prognostic factors. This study represents a multidisciplinary approach, and it is a result of teamwork; it presents histopathological methods of examination of this severe illness and describes only a part of the scientific effort to determine the main pathological mechanisms of this neoplasm.
url http://dx.doi.org/10.1155/2020/6148286
work_keys_str_mv AT vladherlea amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT elenastoicamustafa amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT andreeacristinaiorgescu amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT nicolaecatalinpechianu amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT dragoscretoiu amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT mariasajin amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT simonaolimpiadima amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT catalinvasilescu amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT cezarstroescu amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT constantinungureanu amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT traiandumitrascu amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT vladislavbrasoveanu amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT minervaghinescu amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT irinelpopescu amorphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT vladherlea morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT elenastoicamustafa morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT andreeacristinaiorgescu morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT nicolaecatalinpechianu morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT dragoscretoiu morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT mariasajin morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT simonaolimpiadima morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT catalinvasilescu morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT cezarstroescu morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT constantinungureanu morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT traiandumitrascu morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT vladislavbrasoveanu morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT minervaghinescu morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
AT irinelpopescu morphologicalandimmunohistochemicalstudyofthetumoralandinflammatorycellsinpancreaticductaladenocarcinoma
_version_ 1715087799143628800